154 related articles for article (PubMed ID: 22407500)
1. The effect of adenosine A(2A) receptor antagonists on hydroxyl radical, dopamine, and glutamate in the striatum of rats with altered function of VMAT2.
Gołembiowska K; Dziubina A
Neurotox Res; 2012 Aug; 22(2):150-7. PubMed ID: 22407500
[TBL] [Abstract][Full Text] [Related]
2. Effect of adenosine A(2A) receptor antagonists and L-DOPA on hydroxyl radical, glutamate and dopamine in the striatum of 6-OHDA-treated rats.
Gołembiowska K; Dziubina A
Neurotox Res; 2012 Feb; 21(2):222-30. PubMed ID: 21830163
[TBL] [Abstract][Full Text] [Related]
3. Effect of adenosine A(2A) receptor antagonists on L-DOPA-induced hydroxyl radical formation in rat striatum.
Gołembiowska K; Dziubina A; Kowalska M; Kamińska K
Neurotox Res; 2009 Feb; 15(2):155-66. PubMed ID: 19384578
[TBL] [Abstract][Full Text] [Related]
4. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats.
Gołembiowska K; Dziubina A
Neuropharmacology; 2004 Sep; 47(3):414-26. PubMed ID: 15275831
[TBL] [Abstract][Full Text] [Related]
5. Paradoxical effects of adenosine receptor ligands on hydroxyl radical generation by L-DOPA in the rat striatum.
Gołembiowska K; Dziubina A; Kowalska M; Kamińska K
Pharmacol Rep; 2008; 60(3):319-30. PubMed ID: 18622056
[TBL] [Abstract][Full Text] [Related]
6. Effect of the adenosine A2A receptor antagonist 8-(3-chlorostyryl)caffeine on L-DOPA biotransformation in rat striatum.
Gołembiowska K; Dziubina A
Brain Res; 2004 Feb; 998(2):208-17. PubMed ID: 14751592
[TBL] [Abstract][Full Text] [Related]
7. Effects of adenosine receptor antagonists on the in vivo LPS-induced inflammation model of Parkinson's disease.
Gołembiowska K; Wardas J; Noworyta-Sokołowska K; Kamińska K; Górska A
Neurotox Res; 2013 Jul; 24(1):29-40. PubMed ID: 23296550
[TBL] [Abstract][Full Text] [Related]
8. Reserpine pretreatment prevents increases in extracellular striatal dopamine following L-DOPA administration in rats with nigrostriatal denervation.
Kannari K; Tanaka H; Maeda T; Tomiyama M; Suda T; Matsunaga M
J Neurochem; 2000 Jan; 74(1):263-9. PubMed ID: 10617128
[TBL] [Abstract][Full Text] [Related]
9. The central catechol-O-methyltransferase inhibitor tolcapone increases striatal hydroxyl radical production in L-DOPA/carbidopa treated rats.
Gerlach M; Xiao AY; Kuhn W; Lehnfeld R; Waldmeier P; Sontag KH; Riederer P
J Neural Transm (Vienna); 2001; 108(2):189-204. PubMed ID: 11314772
[TBL] [Abstract][Full Text] [Related]
10. Histamine H(3) receptor ligands modulate L-dopa-evoked behavioral responses and L-dopa derived extracellular dopamine in dopamine-denervated rat striatum.
Nowak P; Bortel A; Dabrowska J; Biedka I; Slomian G; Roczniak W; Kostrzewa RM; Brus R
Neurotox Res; 2008; 13(3-4):231-40. PubMed ID: 18522902
[TBL] [Abstract][Full Text] [Related]
11. Adenosine A 2A receptor antagonists prevent the increase in striatal glutamate levels induced by glutamate uptake inhibitors.
Pintor A; Galluzzo M; Grieco R; Pèzzola A; Reggio R; Popoli P
J Neurochem; 2004 Apr; 89(1):152-6. PubMed ID: 15030399
[TBL] [Abstract][Full Text] [Related]
12. Effects of VMAT2 inhibitors lobeline and GZ-793A on methamphetamine-induced changes in dopamine release, metabolism and synthesis in vivo.
Meyer AC; Neugebauer NM; Zheng G; Crooks PA; Dwoskin LP; Bardo MT
J Neurochem; 2013 Oct; 127(2):187-98. PubMed ID: 23875705
[TBL] [Abstract][Full Text] [Related]
13. Rotenone increases glutamate-induced dopamine release but does not affect hydroxyl-free radical formation in rat striatum.
Leng A; Feldon J; Ferger B
Synapse; 2003 Dec; 50(3):240-50. PubMed ID: 14515342
[TBL] [Abstract][Full Text] [Related]
14. Effects of subchronic treatment with selegiline on L-DOPA-induced increase in extracellular dopamine level in rat striatum.
Adachi K; Miwa H; Kusumoto H; Shimazu S; Kondo T
J Pharmacol Sci; 2006 Aug; 101(4):286-92. PubMed ID: 16891770
[TBL] [Abstract][Full Text] [Related]
15. LPS-induced oxidative stress and inflammatory reaction in the rat striatum.
Noworyta-Sokołowska K; Górska A; Gołembiowska K
Pharmacol Rep; 2013; 65(4):863-9. PubMed ID: 24145080
[TBL] [Abstract][Full Text] [Related]
16. Release of dopamine by perfusion with 1-methyl-4-phenylpyridinium ion (MPP(+)) into the striatum is associated with hydroxyl free radical generation.
Obata T; Yamanaka Y; Kinemuchi H; Oreland L
Brain Res; 2001 Jul; 906(1-2):170-5. PubMed ID: 11430875
[TBL] [Abstract][Full Text] [Related]
17. Effects of iptakalim on extracellular glutamate and dopamine levels in the striatum of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study.
Yang J; Hu LF; Liu X; Zhou F; Ding JH; Hu G
Life Sci; 2006 Mar; 78(17):1940-4. PubMed ID: 16216278
[TBL] [Abstract][Full Text] [Related]
18. 1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline increases extracellular serotonin and stimulates hydroxyl radical production in rats.
Gerlach M; Xiao AY; Heim C; Lan J; God R; Feineis D; Bringmann G; Riederer P; Sontag KH
Neurosci Lett; 1998 Nov; 257(1):17-20. PubMed ID: 9857955
[TBL] [Abstract][Full Text] [Related]
19. Dopamine mediates striatal malonate toxicity via dopamine transporter-dependent generation of reactive oxygen species and D2 but not D1 receptor activation.
Xia XG; Schmidt N; Teismann P; Ferger B; Schulz JB
J Neurochem; 2001 Oct; 79(1):63-70. PubMed ID: 11595758
[TBL] [Abstract][Full Text] [Related]
20. Effect of naloxone on morphine-induced changes in striatal dopamine metabolism and glutamate, ascorbic acid and uric acid release in freely moving rats.
Enrico P; Mura MA; Esposito G; Serra P; Migheli R; De Natale G; Desole MS; Miele M; Miele E
Brain Res; 1998 Jun; 797(1):94-102. PubMed ID: 9630540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
